GILD vs PZZA · P/E 18, rev $29.44B vs P/E 44, rev $2.06B
Gilead Sciences Inc (GILD) versus Papa John's International Inc (PZZA) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Papa John's International Inc (PZZA) is a restaurants company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PZZA revenue for 2024-12-29 was $2.06B. Net income was $84.2M. Revenue was down 3.6% from 2023-12-31 to 2024-12-29. PZZA currently screens at market cap $1.20B and trailing P/E 43.9.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PZZA currently screens at market cap $1.20B and trailing P/E 43.9.
Not investment advice. Open the GILD and PZZA stock pages for the full models.
Not investment advice.